PhytoHealth Corporation

Taiwan Stock Exchange 4108.TW

PhytoHealth Corporation Operating Income for the year ending December 31, 2023: USD -3.96 M

PhytoHealth Corporation Operating Income is USD -3.96 M for the year ending December 31, 2023, a -6.15% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

PhytoHealth Corporation Operating Income for the year ending December 31, 2022 was USD -3.73 M, a -8.71% change year over year.
PhytoHealth Corporation Operating Income for the year ending December 31, 2021 was USD -3.43 M, a 16.66% change year over year.
PhytoHealth Corporation Operating Income for the year ending December 31, 2020 was USD -4.12 M, a 39.74% change year over year.
PhytoHealth Corporation Operating Income for the year ending December 31, 2019 was USD -6.84 M, a 22.20% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Taiwan Stock Exchange: 4108.TW

PhytoHealth Corporation

CEO	Ms. Yi-Li Lee
IPO Date	July 16, 2008
Location	Taiwan
Headquarters	No.167, Fu Hsing North Road
Employees	84
Sector	Health Care
Industries Pharmaceuticals

Description

PhytoHealth Corporation researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and supplementary foods and other related products. Its products include PG2 Lyophilized injection for the treatment of cancer related fatigue; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company also offers precision medical equipment and instrument; medical diagnosis software; and computer-aided diagnosis system authorization services. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Key trends

Past 5 years